创新医药生物科技有限公司（<0399.HK>）于2025年7月16日宣布，将配发及发行6000万股A类认购股份，每股定价为0.312港元。 同时，公司计划发行3000万股B类认购股份，每股认购价同样定为0.312港元。 此次配股行动旨在增强资本实力，为未来发展提供资金支持；投资者需关注后续公告，以获取更多细节。
创新医药生物科技有限公司（<0399.HK>）于2025年7月16日宣布，将配发及发行6000万股A类认购股份，每股定价为0.312港元。 同时，公司计划发行3000万股B类认购股份，每股认购价同样定为0.312港元。 此次配股行动旨在增强资本实力，为未来发展提供资金支持；投资者需关注后续公告，以获取更多细节。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.